Tsung‐Ming Chen

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen et al. · Liver International · 2016 · 217 citations

Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high‐risk for hepatocellular carcinoma

Sheng‐Nan Lu, Jing‐Houng Wang, Shiann‐Long Liu et al. · Cancer · 2006 · 158 citations

Neutrophil‐to‐lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation

Tsung‐Ming Chen, Chun‐Che Lin, Pi‐Teh Huang et al. · Journal of Gastroenterology and Hepatology · 2011 · 137 citations

Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation

Tsung‐Ming Chen, Chun‐Che Lin, Pi‐Teh Huang et al. · Journal of Gastroenterology and Hepatology · 2011 · 109 citations · Full text

Predictors of alpha‐fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a–ribavirin combination therapy

Tsung‐Ming Chen, Pi‐Teh Huang, Ming‐Hung Tsai et al. · Journal of Gastroenterology and Hepatology · 2007 · 89 citations